STRIDE 在亚洲肝细胞癌中的疗效和安全性

IF 26.8 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Journal of Hepatology Pub Date : 2024-10-05 DOI:10.1016/j.jhep.2024.10.001

Zaoqu Liu, Dan Shan, Xinwei Han

引用次数: 0

摘要

章节片段作者贡献刘兆渠：研究设计与稿件撰写单丹、韩新伟：研究设计与稿件修改利益冲突声明我们声明不存在任何利益冲突。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

STRIDE's Efficacy and Safety in Asian Hepatocellular Carcinoma

Section snippets

Author’s contributions

Zaoqu Liu: Study design & Manuscript Writing.Dan Shan and Xinwei Han: Study design & Manuscript Revision.

Declaration of Competing Interest

We declare there is no any conflict of interest.

Acknowledgements & Funding

None

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Hepatology 医学-胃肠肝病学

CiteScore

46.10

自引率

4.30%

发文量

2325

审稿时长

30 days

期刊介绍： The Journal of Hepatology is the official publication of the European Association for the Study of the Liver (EASL). It is dedicated to presenting clinical and basic research in the field of hepatology through original papers, reviews, case reports, and letters to the Editor. The Journal is published in English and may consider supplements that pass an editorial review.